These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28233302)

  • 1. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
    Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
    Nakatani K; Serada S; Fujimoto M; Obata K; Ohkawara T; Sasabe E; Yamamoto T; Naka T
    J Oral Pathol Med; 2022 Feb; 51(2):126-133. PubMed ID: 34878693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
    Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Ohkawara T; Hiramatsu K; Nishida T; Hirota S; Saito Y; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Hanasaki K; Kishimoto T; Mori M; Doki Y; Naka T
    Gastric Cancer; 2018 Nov; 21(6):968-976. PubMed ID: 29623544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
    Kajiyama T; Serada S; Fujimoto M; Ohkawara T; Komori M; Hyodo M; Naka T
    Anticancer Res; 2022 Jul; 42(7):3361-3372. PubMed ID: 35790291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
    Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
    Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.
    Li LY; Jiang H; Xie YM; Liao LD; Cao HH; Xu XE; Chen B; Zeng FM; Zhang YL; Du ZP; Chen H; Huang W; Jia W; Zheng W; Xie JJ; Li EM; Xu LY
    Oncotarget; 2015 Jun; 6(18):15940-52. PubMed ID: 25909284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
    Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
    Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
    Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
    Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC
    Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy.
    Ma W; Zhang T; Pan J; Shi N; Fan Q; Wang L; Lu SH
    Oncol Rep; 2014 Oct; 32(4):1601-9. PubMed ID: 25175038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
    Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
    Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.